Flørenes T, Zasada W, Bille S, Pillgram-Larsen J, Dedichen H
Kar/thoraxkirurgisk avdeling, Ullevål sykehus, Oslo.
Tidsskr Nor Laegeforen. 1994 Nov 10;114(27):3193-4.
Since Kunlin's report on femoropopliteal bypass operations, this procedure, with homologous vein or various prosthesis has been the principal treatment for serious arteriosclerosis in this anatomical area. During the years 1979-88 we performed 235 femoropopliteal bypasses. Reversed autologous vein was used in 60% and the distal anastomosis placed below the knee in 75%. Perioperative, 30 days mortality was 2.1%. 93% of the operations were successful. The overall five year patency rate was 50.6%, but with significantly better results with the distal anastomosis above the knee. There was no significant difference, however, between reversed homologous vein and human umbilical vein grafts in the below knee position. At present, the indications for femoropopliteal bypass are critical ischemia and seriously incapacitating claudication.
自从昆林报道股腘动脉搭桥手术以来，采用同种异体静脉或各种假体进行的这一手术，一直是该解剖区域严重动脉硬化的主要治疗方法。在1979年至1988年期间，我们进行了235例股腘动脉搭桥手术。60%使用了自体静脉反转移植，75%的远端吻合位于膝关节以下。围手术期30天死亡率为2.1%。93%的手术获得成功。总体五年通畅率为50.6%，但远端吻合位于膝关节以上时效果明显更好。然而，在膝关节以下位置，自体静脉反转移植与人脐静脉移植物之间没有显著差异。目前，股腘动脉搭桥的适应证是严重缺血和严重致残性跛行。
